Links recommended by Dr. Lucire
Concern over suicide rate of mental health patients.
31/01/2005. ABC News Online
Link
Antidepressants and Suicide: Risk-Benefit Conundrums David Healy MD
www.healyprozac.com/GhostlyData/JPCNDHealy.pdf
Defining Genetic Influences on Pharmacologic Responses
http://medicine.iupui.edu/flockhart/
Healthy Skepticism: Countering misleading drug promotion
http://www.healthyskepticism.org/
DrugDigest
http://www.drugdigest.org
International Journal of Risk & Safety in Medicine
16 (2003/2004) 31–49 31
IOS Press
Suicidality, violence and mania caused by selective serotonin reuptake
inhibitors (SSRIs): A review and analysis
Peter R. Breggin
www.breggin.com/31-49.pdf
Dr. Ann Blake Tracy, International Coalition for Drug Awareness – Ann Blake
Tracey author of Prozac: Panacea or Pandora?
http://www.disinfo.com
http://www.sntp.net/prozac/breggin_prozac_1.htm
http://www.postgradmed.com/issues/2003/08_03/ditto.htm
http://www.biopsychiatry.com/
http://www.healyprozac.com
AHRP
Mission Statement
The Alliance for Human Research Protection (AHRP) is a national network of lay
people and professionals dedicated to advancing responsible and ethical medical
research practices, to ensure that the human rights, dignity and welfare of
human subjects are protected, and to minimize the risks associated with such
endeavors.
http://www.ahrp.org
Social Audit
This website began as an investigation of problems with antidepressant drugs –
not only their adverse effects on many users, but also what the problem
signalled about the conduct of the competent authorities, and the adequacy of
their institutions and process. As the problem unfolded, notably between 1997
and 2003, it revealed a glimpse of pharmageddon - a world of sickness created
and sustained by exploitation of the fear of disease, indifference to real
health needs, dependence on authority, and misplaced trust in the triumph of
drug benefits over harm. These are the main themes in Medicines out of Control?
http://www.socialaudit.org.uk
United States Food and Drug Administration.
http://www.fda.gov/cder/drug/default.htm#Clinical%20Trials
FDA Public Health Advisory
March 22, 2004
FDA: Worsening Depression And Suicidality in Paitients Being
Treated with Antidepressant Medications
http://www.fda.gov/cder/drug/antidepressants/AntidepressanstPHA.htm
FDA Talk Paper
T03-70
October 27, 2003
http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01283.html
FDA: Issues Public Health Advisory Entitled: Reports Of Suicidality in
Pediatric Patients Being Treated with Antidepressant Medications for Major
Depressive Disorder (MDD)
http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01256.html
Adverse Drug Reactions Advisory Committee
(Replaces statement of 17 June 2004)
http://www.tga.gov.au/adr/adrac_ssri.htm
Eli Lilly and Company Clinical Trial Registry
This site contains information about clinical trials sponsored by Eli Lilly and
Company. This information is not intended to replace the advice of a health
care professional. Only a physician can determine if a specific medicine is the
correct treatment for a particular patient. If you have questions regarding any
information contained in this site, please consult a physician.
http://www.lillytrials.com
 Back
to top
|